Save Skin Cancer Care — America is winning the war on skin cancer
Save Skin Cancer Care
A national campaign

America is winning the war on skin cancer. Don’t surrender now.

Skin cancer is the most common cancer in America, and early detection makes a profound difference: localized melanoma has a five-year relative survival rate of 99%. A new Medicare proposal would cut the local care that makes early intervention possible. That’s why we are fighting to Save Skin Cancer Care!

#1

skin cancer is the most common cancer in America

9,500

Americans diagnosed with approximately 15,000 skin cancers daily

6.1 million

Americans treated for skin cancer each year

1 in 5

Americans will develop skin cancer in their lifetime

What CMS proposed

A proposed cut aimed at the front lines of skin cancer care

Dermatology absorbs $291 million — approximately 30% — of all national Modifier 25 cuts, despite accounting for only 4.1% of physician specialty spending and just 0.28% of total Medicare Part B expenditures.

Just 50 CPT codes comprise 98% of all procedural services performed by dermatologists for Medicare patients, and 91% of those services are related to skin cancer treatment, prevention, and detection. Under the proposal, 72% of dermatologists would face cuts greater than 15%.

Disproportionate impact

$291M

in estimated dermatology cuts under the proposed Modifier 25 policy.

~30%

of national Modifier 25 cuts

4.1%

of physician specialty spending

0.28%

of total Medicare Part B expenditures

For policy readers: the details+

The proposed Modifier 25 policy would reduce payment by 50% when a separately identifiable evaluation and management visit and a qualifying procedure are provided on the same day. The proposal would also phase out the Indirect Practice Cost Index used to account for practice overhead.

Why a billing rule reaches your skin check

The service being cut in half is the one that catches cancer

Here is how skin cancer gets caught today — and exactly where the proposal breaks it. Keep scrolling.

STEP 01

One exam

A patient comes in for a routine skin check. One visit, one drive.

STEP 02

A spot is found

The dermatologist sees a suspicious lesion during the exam.

STEP 03

Biopsied on the spot

Same visit, same room. No second appointment, no second drive.

STEP 04

Answers within days

Localized melanoma has a five-year relative survival rate of 99%.

UNDER THE PROPOSAL

That same-day biopsy pays only half.

A payment reduction could make it harder for practices to provide same-day evaluation and biopsy.

01 / 05

14 states where Medicare payment for skin cancer care would fall below Medicaid

Oregon, Idaho, Nevada, Arizona, South Dakota, Oklahoma, Missouri, Mississippi, Alabama, Indiana, South Carolina, Maryland, Delaware, and Vermont

Impact on key states

Proposed cuts would mean less access and longer waits

If not corrected, the cuts would block access to care as Medicare funding for skin cancer care falls below Medicaid rates in 14 states.

See what Americans think of the cuts →
Who gets hurt

Skin cancer does not strike evenly

Seniors, rural Americans, and veterans face some of the greatest risks from skin cancer and the proposed cuts.

65+

Older Americans

Most skin cancer occurs in Americans age 65 and older.

88%

Rural Americans

Nearly 9 in 10 rural counties have no dermatologist.

4×

Veterans

face a four-times higher rate of melanoma than civilians.

Has early detection saved someone you love? Share your story →

The stakes

Early beats late. Every time, in every way.

For localized melanoma, the five-year relative survival rate is 99%. After the disease has spread to distant parts of the body, it is 35%.

Melanoma five-year survival

Early Care 99%
Delayed Care 35%

Caught early

<$1,000

Excision under local anesthetic at a dermatology office.

250×

the cost when caught late

Caught late

$250,000+

Melanoma treatment with immunotherapy.

What we’re asking

Three fixes, all within CMS’ power

01

Withdraw the same‑day cut

Withdraw the 50% payment cut for same-day procedures, so patients can keep getting a suspicious spot checked and biopsied in one visit.

02

Withdraw the IPCI phase-out

Maintain accurate overhead accounting for independent practices rather than relying on flawed formulas government researchers warned against.

03

Provide inflationary payment updates

Align Medicare physician payment updates with real-world inflation to stabilize independent small practices and safeguard senior access to care.

About the campaign

Who we are

Save Skin Cancer Care is a national campaign of dermatologists, clinicians, patients, and communities who believe the fight against America’s most common cancer should not be defunded just as we’re winning it. We bring the evidence, the economics, and the voices of the people early detection has saved.

Read and sign the Community Statement →

The proposal is under review right now. So is your voice.

The cut is a draft, currently under review by federal health officials, and the government is accepting public comments. Every signature and every comment makes the record harder to ignore. Once the rule is final, it is too late.

Sign the Community Statement Share your story
Americans diagnosed with skin cancer since you opened this page: 0